Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Hikma Pharmaceuticals USA, Inc.
FDA Inspection
•Hikma Pharmaceuticals USA, Inc.•June 30, 2011

Hikma Pharmaceuticals USA, Inc. – FDA Inspection, Jun 30, 2011

Record Details

This FDA Inspection record concerns Hikma Pharmaceuticals USA, Inc., with an inspection on June 30, 2011, issued by the Center for Veterinary Medicine, covering veterinary.

Company
Hikma Pharmaceuticals USA, Inc.
Inspection Date
June 30, 2011
Product Type
Veterinary
Office
Center for Veterinary Medicine
View Company Profile

ID · ee678069-a771-4c99-8242-c0c3a8ce6178

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
732560
FDA center
Animal Drugs & Feeds
Project area
Monitoring of Marketed Animal Drugs, Feed, and Devices

FDA Citations

10
  1. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  2. 21 CFR 211.160(a)Deviations from laboratory control requirements
  3. 21 CFR 211.142(b)Storage under appropriate conditions
  4. 21 CFR 211.63Equipment Design, Size and Location
  5. 21 CFR 211.186(b)(7)Theoretical yield statement including percentages
  6. 21 CFR 211.100(a)Absence of Written Procedures
  7. 21 CFR 211.192Investigations of discrepancies, failures
  8. 21 CFR 211.111Establishment of time limitations
  9. 21 CFR 211.180(e)(2)Items to cover on annual reviews
  10. 21 CFR 211.67(b)Written procedures not established/followed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Hikma Pharmaceuticals USA, Inc.

12
DateClassificationOfficeProject area
February 1, 2019NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
April 13, 2018NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 7, 2016NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 10, 2015NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
February 26, 2014VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 12 other inspections on the company page
Other documents for Hikma Pharmaceuticals USA, Inc.
  • FDA Inspection 1079961 - 2019-02-01
  • FDA Inspection 1054739 - 2018-04-13
  • FDA Inspection 976090 - 2016-07-07
  • FDA Inspection 942928 - 2015-09-10
  • FDA Inspection 864847 - 2014-02-26

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hikma Pharmaceuticals USA, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.